The European Respiratory Society (ERS) Congress, held in Barcelona, Spain, highlighted new clinical strategies and therapies reinforcing that chronic obstructive pulmonary disease (COPD) is a modifiable condition where patient outcomes can be improved at every stage.
Authored by Chris Carlin from the West of Scotland Innovation Hub and Department of Respiratory Medicine, NHS Greater Glasgow & Clyde, UK, the congress review detailed findings from key sessions. Presentations focused on overcoming historical challenges of late diagnosis and unreviewed treatments through earlier case-finding, quality improvement programs, structured primary care reviews, and emerging treatments.
Key highlights discussed at the ERS event included:
- Improving Care Pathways: Presentations showed how outcomes can improve at every stage, from earlier diagnosis and structured review, emphasizing that COPD is a modifiable disease.
- Transforming Care: Experts emphasized that respiratory care pathways should be reoriented towards proactive, personalised, and guideline-based management, underpinned by better case-finding and data-driven care.
- Diagnostic Innovations: Data and discussions highlighted the need to integrate transformation initiatives across entire care pathways rather than delivering them in isolation, ensuring the rapid adoption and rigorous evaluation of assistive technologies and evidenced therapies.
- Equitable Delivery: Crucially, these interventions must be delivered equitably so that the benefits reach those with the greatest need.
Experts concluded that while significant progress has been made, we must continue integrating transformation initiatives across entire care pathways to ensure the rapid adoption and rigorous evaluation of assistive therapies and evidenced treatments.